ArticleThe Journal of infection2020
REPLY TO: Interleukin-17: a potential therapeutic target in COVID-19.
Stefano Piaserico et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleThe Journal of infection2020
Stefano Piaserico et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.